Pro zobrazení tohoto obsahu je třeba být přihlášen.
Categories for Uncategorized
Unicancer GI PRODIGE 24/CCTG PA.6 trial: A multicenter international randomized phase III trial of adjuvant mFOLFIRINOX versus gemcitabine (gem) in patients with resected pancreatic ductal adenocarcinomas
23 septembra, 2020 4:52 pmMeeting: 2018 ASCO Annual Meeting Track: Gastrointestinal (Noncolorectal) Cancer Abstract number: LBA4001 Authors: Thierry Conroy, Pascal Hammel,...
KEYNOTE-164: Pembrolizumab for patients with advanced microsatellite instability high (MSI-H) colorectal cancer
23 septembra, 2020 4:52 pmMeeting: 2018 ASCO Annual Meeting Track: Gastrointestinal (Colorectal) Cancer Abstract number: 3514 Authors: Dung T. Le, Petr...
High-Dose Acid Suppression for Preventing Esophageal Adenocarcinoma in Patients With Metaplasia
23 septembra, 2020 4:52 pmJune 4, 2018 Adjuvant chemotherapy with a modified FOLFIRINOX (mFOLFIRINOX) regimen was superior to gemcitabine with regard to disease-free,...
Chemoprevention of esophageal cancer with esomeprazole and aspirin therapy: Efficacy and safety in the phase III randomized factorial ASPECT trial
23 septembra, 2020 4:52 pmMeeting: 2018 ASCO Annual Meeting Track: Gastrointestinal (Noncolorectal) Cancer Abstract number: LBA4008 Authors: Janusz Jankowski, John de...
High-Dose Acid Suppression for Preventing Esophageal Adenocarcinoma in Patients With Metaplasia
23 septembra, 2020 4:52 pmJune 4, 2018 A high dose of a proton-pump inhibitor (PPI) combined with low-dose aspirin reduced the risk of...
Najvýznamnejšie klinické správy z konferencie ASCO 2018 v problematike nádorov gastrointestinálneho traktu
23 septembra, 2020 4:52 pmPočas prvého júnového týždňa tohto roka sa konal v Chicagu tradičný výročný kongres Americkej onkologickej spoločnosti (ASCO). Ako obvykle v rámci prednášok...
Overall survival in COLUMBUS: A phase 3 trial of encorafenib (ENCO) plus binimetinib (BINI) vs vemurafenib (VEM) or enco in BRAF-mutant melanoma
23 septembra, 2020 4:52 pmMeeting: 2018 ASCO Annual Meeting Track: Melanoma/Skin Cancers Abstract number: 9504 Authors: Reinhard Dummer, Paolo Antonio Ascierto,...
Anti-PD1 antibodies in late elderly advanced melanoma patients: A retrospective multicentre study
23 septembra, 2020 4:52 pmMeeting: 2018 ASCO Annual Meeting Track: Patient and Survivor Care Abstract number: 10 038 Authors: Francesco De Rosa,...
Characterization of complete responders to combination nivolumab (nivo) and ipilimumab (ipi) in patients (pts) with advanced, unresectable melanoma
23 septembra, 2020 4:52 pmMeeting: 2018 ASCO Annual Meeting Track: Melanoma/Skin Cancers Abstract number: 9552 Authors: Allison Betof Warner, Alexander Noor...
Four-Year Data Show Durable Effect of Pembrolizumab in Advanced Melanoma
23 septembra, 2020 4:52 pmJune 4, 2018 The anti–PD-1 antibody pembrolizumab previously demonstrated superior overall survival (OS) in patients with advanced melanoma compared...